Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins.

JCO precision oncology - 1 May 2024

Tanaka Ryuma, Mrachek Kelly, Arocho-Quinones Elsa, Carlberg Valerie M, Smith Candice, Kurzrock Razelle, Deshmukh Tejaswini

Abstract excerpt

This report highlights the first pediatric case of pilocytic astrocytoma with BRAF V599ins mutation, successfully treated with dabrafenib.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms
Share to Child
Share to BRAF gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imidazoles

Share to Mutation

Share to Oximes

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 38781546
DOI: 10.1200/PO.24.00055

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins.PMID 38781546Read ↗

Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.Semantic proximity Read ↗

MEK Inhibition in a Pilocytic Astrocytoma With a Rare KRAS Q61R Mutation in a Young Adult Patient: A Case Report.Semantic proximity Read ↗

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation.Semantic proximity Read ↗

Impact of BRAF/MEK inhibitor on BRAF V600E-mutated pilocytic astrocytoma.Semantic proximity Read ↗

Metastatic Low-Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation.Semantic proximity Read ↗

Emerging paradigm: Molecularly targeted therapy with Dabrafenib and Trametinib in recurring pediatric gliomas with BRAF mutations: A narrative review.Semantic proximity Read ↗

The role of BRAF-targeted therapy in astrocytomas: a review.Semantic proximity Read ↗

Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with BRAF p.T599dup mutation.Semantic proximity Read ↗

Dabrafenib and trametinib in BRAFV600E mutated glioma.Semantic proximity Read ↗

Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion.Semantic proximity Read ↗

Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.Semantic proximity Read ↗

Pilocytic astrocytoma in adults: Histopathological, immunohistochemical and molecular study with clinical association.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.